The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

Youngji Jo; David W. Dowdy

doi:10.1016/S1473-3099(19)30054-4

The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	675-676
Number of pages	2
Journal	The Lancet Infectious Diseases
Volume	19
Issue number	7
DOIs	https://doi.org/10.1016/S1473-3099(19)30054-4
State	Published - Jul 2019

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1016/S1473-3099(19)30054-4

Cite this

@article{31f6c8acab584681b255090a3de66212,

title = "The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection",

author = "Youngji Jo and Dowdy, {David W.}",

year = "2019",

month = jul,

doi = "10.1016/S1473-3099(19)30054-4",

language = "English (US)",

volume = "19",

pages = "675--676",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "7",

}

TY - JOUR

T1 - The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

AU - Jo, Youngji

AU - Dowdy, David W.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85067865224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067865224&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(19)30054-4

DO - 10.1016/S1473-3099(19)30054-4

M3 - Comment/debate

C2 - 31130328

AN - SCOPUS:85067865224

SN - 1473-3099

VL - 19

SP - 675

EP - 676

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 7

ER -

The economic case for typhoid conjugate vaccines in countries with medium and high incidence of infection

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this